Journal article icon

Journal article

QRISK3 underestimates the risk of cardiovascular events in patients with COPD

Abstract:
Background: Patients with chronic obstructive pulmonary disease (COPD) are at increased risk of cardiovascular disease (CVD). The extent to which the excess CVD risk is captured by risk factors in QRISK, a widely used CVD risk scoring tool, is not well studied. // Methods: We created an incidence cohort of diagnosed COPD patients from the United Kingdom (UK) Clinical Practice Research Datalink GOLD database (January 1998–July 2018). The outcome was a composite of fatal or non-fatal CVD events. Sex-specific age-standardised incidence ratios (SIR) were compared with values for the UK primary-care population. The observed 10-year CVD risk was derived using the Kaplan-Meier estimator and was compared with predicted 10-year risk from the QRISK3 tool. // Results: 13 208 patients (mean age 64.9 years, 45% women) were included. CVD incidence was 3.53 events per 100 person-years. The SIR of CVD was 1.71 (95% CI 1.61 to 1.75) in women and 1.62 (95%CI 1.54–1.64) in men. SIR was particularly high among patients younger than 65 years (women=2.13 (95% CI 1.94 to 2.19); men=1.86 (95% CI 1.74 to 1.90)). On average, the observed 10-year risk was 52% higher than QRISK predicted score (33.5% vs 22.1%). The difference was higher in patients younger than 65 years (observed risk 82% higher than predicted). // Conclusion: People living with COPD are at a significantly heightened risk of CVD over and beyond their predicted risk. This is particularly the case for younger people whose 10-year CVD risk can be >80% higher than predicted. Risk scoring tools must be validated and revised to provide accurate CVD predictions in patients with COPD
Publication status:
Published
Peer review status:
Peer reviewed

Actions

Access Document

Files:
Publisher copy:
10.1136/thorax-2023-220615
Publication website:
https://discovery.ucl.ac.uk/10183367/1/thorax-2023-220615.full.pdf

Authors

More by this author
Role:
Author
ORCID:
0000-0002-0459-7241
More by this author
Role:
Author
ORCID:
0000-0002-5313-4884
More by this author
Role:
Author
ORCID:
0000-0003-0149-4869
More by this author
Institution:
University of Oxford
Role:
Author
ORCID:
0000-0002-3890-7201
More by this author
Role:
Author
ORCID:
0000-0002-7246-6040


More from this funder
Funder identifier:
10.13039/501100004489
Grant:
no award/grant number
More from this funder
Funder identifier:
10.13039/501100000024
Grant:
Team Grant PHT 178432


Publisher:
BMJ Publishing Group
Journal:
Thorax More from this journal
Volume:
79
Issue:
8
Pages:
718-724
Publication date:
2023-11-27
Acceptance date:
2023-10-26
DOI:
EISSN:
1468-3296
ISSN:
0040-6376


Language:
English
Keywords:
Pubs id:
1578022
Local pid:
pubs:1578022
Source identifiers:
W4389058666
Deposit date:
2026-06-04
ARK identifier:
This ORA record was generated from metadata provided by an external service. It has not been edited by the ORA Team.

Terms of use


Views and Downloads






If you are the owner of this record, you can report an update to it here: Report update to this record

TO TOP